Nationwide Recall Issued for Levothyroxine Sodium Tablets Due to Potency Issues

Major Pharmaceuticals has issued a voluntary nationwide recall of multiple lots of levothyroxine sodium tablets, a commonly prescribed thyroid medication. The recall is due to the drug being "subpotent," meaning it may not contain the advertised amount of active ingredient. The affected tablets include various strengths and counts, with expiration dates ranging from July 2026 to January 2027.